Recursion OS is an AI-powered drug discovery and development platform built on massive proprietary biological and chemical datasets.
The Recursion Operating System (OS) spans target identification to clinical trial enrollment by combining automated high-throughput labs, multi-omics data, and machine-learning foundation models.
It generates maps of biology and chemistry to discover novel therapeutic candidates and improve the drug discovery process iteratively.
Atomic AI
ATOM-1
atomic.ai
Lila Sciences
Catalyst, Creation
lila.ai
Enveda Biosciences
Enveda Drug Discovery Platform
enveda.com
Genesis Therapeutics
GEMS AI Platform
genesistherapeutics.ai
1910
ITO Platform
1910genetics.com
Origin Bio
Origin Bio — Cancer Biology Platform
origin.bio
| Attribute | Recursion OS | ATOM-1 | Catalyst, Creation | Enveda Drug Discovery Platform | GEMS AI Platform | ITO Platform | Origin Bio — Cancer Biology Platform | |
|---|---|---|---|---|---|---|---|---|
| Provider |  | | | | | | | |
| Founded | 2013 | 2021 | 2023 | 2019 | 2019 | 2018 | 2025 | |
| Sells To | Enterprise | Enterprise | Enterprise | Enterprise | Enterprise | Enterprise | B2B, Pharmaceutical Manufacturers | |
| Pricing Model | Recurring, Software | Recurring | — | Recurring | Recurring, Software | Recurring, Software | B2B, Licensing | |
| Ownership | Public, Venture Capital | Venture Capital | Venture-backed private company | Venture Capital | Venture Capital | Private Equity, Venture Capital | Private |
Provider
Founded 2013
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public, Venture Capital
Provider
Founded 2021
Sells To Enterprise
Pricing Model Recurring
Ownership Venture Capital
Provider
Founded 2023
Sells To Enterprise
Pricing Model —
Ownership Venture-backed private company
Provider
Founded 2019
Sells To Enterprise
Pricing Model Recurring
Ownership Venture Capital
Provider
Founded 2019
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture Capital
AI Drug Discovery Platform
